<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2017</study_start_year><condition>Multi-disciplinary Treatment</condition><condition>Colorectal Neoplasms</condition><data_sharing_plan>IPD Sharing (as of January 2018): No</data_sharing_plan><disease>Multi-disciplinary Treatment</disease><disease>Colorectal Neoplasms</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2263381</full_dataset_link><location>China</location><study_start_month>11</study_start_month><repository>ECRIN MDR</repository><study_status>Not provided</study_status></additional><is_claimable>false</is_claimable><name>MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer</name><description>This is a prospective, multicenter, non-interventional, controlled clinical study. Evaluate MDT performance and benefit analysis in patients with advanced gastric or colorectal cancer after MDT discussion under real medical practice.</description><dates><creation>2017-11-15</creation></dates><accession>2263381</accession><cross_references><ClinicalTrials___gov>NCT03400657</ClinicalTrials___gov></cross_references></HashMap>